ThorGene
Latest round
- Series A
Last raised
- Jan 2016
Total raised
- Undisclosed
Investors
- 1
About ThorGene
Established in 2011 and based in Beijing, China, ThorGene is a gene technology company that provides molecular diagnosis and treatment services based on big data technology. The company is headquartered in Beijing and has branches in Nanjing and Suzhou. The company's main business is providing customized and precise health and medical services through genetic testing and data analysis. The company's self-developed platforms and technologies include a multidimensional life data analysis platform, medical data analysis technology, liquid tumor biopsy technology, and highly sensitive digital PCR instruments. Its products are used in the field of precision medicine, offering solutions for disease prevention and tumor clinical testing. The company generates revenue by offering a comprehensive suite of genetic testing services, data analysis solutions, and precision health management.
Who invested in ThorGene
1 investor across 1 round
See all investors in ThorGene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 14, 2016
Amount
Undisclosed
Investors
Questions about ThorGene
Who invested in ThorGene?
ThorGene has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ThorGene raised?
ThorGene has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ThorGene last raise money?
ThorGene's most recent round on record is a Series A, in Jan 2016.
What does ThorGene do?
Established in 2011 and based in Beijing, China, ThorGene is a gene technology company that provides molecular diagnosis and treatment services based on big data technology.
Where is ThorGene headquartered?
ThorGene is headquartered in Beijing, China.
Which VCs invest in companies like ThorGene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ThorGene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ThorGene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.